Teri Loxam is the founder of SQZ Biotech. SQZ Biotech has raised $200M in total funding. Latest round: Series D. Backed by Temasek, GV, Illumina Ventures.
Teri Loxam is the Chief Financial Officer (CFO) of SQZ Biotech, a company based in Watertown, Massachusetts, that focuses on developing cell therapies for cancer and other serious diseases using its Cell Squeeze approach to cell engineering. She played a key role in the company's financial operations, investor relations, and communications/public relations. Loxam helped SQZ Biotech raise over $200 million in private and public funding, including an IPO on the NYSE in October 2020. She has prior experience at Merck, IMAX Corporation, and Bristol-Myers Squibb in strategy, investor relations, treasury, and communications.
Full founder directory · Investor directory · Company funding database · Fundraising library